1. Home
  2. ENTX vs SHMD Comparison

ENTX vs SHMD Comparison

Compare ENTX & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.70

Market Cap

142.0M

Sector

Health Care

ML Signal

HOLD

Logo SCHMID Group N.V. Class A Ordinary Shares

SHMD

SCHMID Group N.V. Class A Ordinary Shares

HOLD

Current Price

$5.92

Market Cap

216.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTX
SHMD
Founded
2010
1864
Country
Israel
Germany
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
142.0M
216.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ENTX
SHMD
Price
$1.70
$5.92
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
124.4K
208.8K
Earning Date
11-14-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$124,000.00
$85,165,542.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.25
N/A
52 Week Low
$1.50
$1.86
52 Week High
$3.22
$6.70

Technical Indicators

Market Signals
Indicator
ENTX
SHMD
Relative Strength Index (RSI) 30.09 63.97
Support Level $1.69 $4.70
Resistance Level $2.22 $5.40
Average True Range (ATR) 0.14 0.64
MACD -0.03 0.07
Stochastic Oscillator 19.28 77.36

Price Performance

Historical Comparison
ENTX
SHMD

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

Share on Social Networks: